In recent years, the landscape of mental health care has evolved dramatically, with online therapy emerging as a viable alternative to traditional in-person sessions. Despite its potential, many patients show reluctance to engage in online therapy trials, particularly those involving cognitive behavioural therapy (CBT) for depression. Understanding the reasons behind this hesitation is crucial to improving recruitment for such trials and enhancing the delivery of mental health services.
The integration of therapist-led sessions with CBT materials on a single online platform can be an effective approach for individuals with depression. However, a mixed-methods study conducted across three UK trial sites revealed that 40.3% of 1799 invited patients declined participation. The primary reasons were a disinterest in participating in research, reluctance towards online therapy, and scepticism about CBT itself.
Understanding Patient Reluctance
The study identified several factors influencing patients' decisions to decline participation. Personal circumstances often played a significant role, with depressive symptoms or other mental health issues acting as barriers. Additionally, many patients expressed uncertainty about receiving CBT online, influenced by past experiences and perceptions of eligibility.
Perceptions of Mental Health
Patients' perceptions of their mental health status significantly impacted their willingness to participate. Some individuals did not consider themselves currently depressed, managing their symptoms through lifestyle changes or medication. Others felt that their primary mental health concern was not depression but anxiety or other disorders, leading them to exclude themselves from the trial.
Previous Experiences with CBT
Previous negative experiences with CBT also deterred participation. Challenges with the written components and homework often left patients feeling that CBT was not suitable for them. Conversely, those who had benefited from CBT in the past felt no need to re-engage, viewing it as a short-term solution.
Concerns About Online Therapy
While online therapy is increasingly accepted, especially post-pandemic, concerns persist. Many patients prefer in-person therapy, valuing the rapport and communication it fosters. Misunderstandings about the nature of online sessions, particularly the use of typing rather than video calls, further contributed to hesitance. Privacy concerns and the challenge of conveying emotions through text were also significant deterrents.
Addressing the Challenges
To enhance recruitment and engagement in online therapy trials, it is essential to address these concerns. Clear communication about the trial's nature and the online therapy process can mitigate misunderstandings. Personalised approaches that consider individual patient needs and preferences may also increase acceptance.
General practitioners (GPs) play a vital role in this process. By discussing potential concerns during consultations, GPs can reassure patients about their eligibility and the benefits of the intervention. Further, tailoring recruitment strategies to align with patients' current mental health status and readiness for therapy could improve participation rates.
In conclusion, while online CBT presents a promising avenue for treating depression, overcoming patient reluctance requires understanding their perspectives and addressing their concerns. By fostering trust and clarity, we can enhance the effectiveness and reach of mental health services, ultimately improving patient outcomes.
Source: Patients’ reasons for declining a primary care trial online therapy: